WebbCurrent and historical debt to equity ratio values for Dr Reddy's Laboratories (RDY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial … Webb19 mars 2024 · Dr. Reddy's Laboratories Synopsis NSE-Medical-Diversified Dr. Reddy's Labs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 14405.20 Cr. and Equity Capital is Rs. 83.20 Cr. for the Year ended 31/03/2024. Dr.
(PDF) Dr Reddy’s Laboratories Ltd.: creating a competitive …
Webb24 juli 2024 · Dr. Reddy's Laboratories. (2024). Value of Dr. Reddy's Laboratories Limited monthly share trade at National Stock Exchange in financial year 2024 (in Indian rupees). … WebbWe invert the residual income valuation model (using current stock prices, current book value of equity and short-term forecasts of accounting earnings) to obtain an estimate of the expected... china energy middle east
Dr. Reddy
Webb7 apr. 2024 · Dr. Reddy’s Laboratories (Excluding its subsidiaries) has filed 541 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 222 have been granted leading to a grant rate of 45.03%. Below are the key stats of Dr. Reddy’s Laboratories patent prosecution at the USPTO. WebbDr Reddy's Labs Share Price - Get Dr Reddy's Labs Ltd LIVE BSE/NSE stock price with Performance, Fundamentals, Market Cap, Share holding, financial report ... Book Value: 1251.38: Debt to Equity: 0.08: Face Value: 5: Understand Fundamentals. Financials *All values are in Rs. Cr. No Graph Data To Display. Quarterly. Yearly. Webb3 feb. 2024 · Enter the characters shown in the image. Dr Reddy's Laboratories on Thursday said it has inked a pact to acquire Germany-based Nimbus Health GmbH. The drug major said it has entered into a definitive agreement to acquire the company which is a privately owned, licensed pharmaceutical wholesaler focusing on medical cannabis in … china energy outlook 2030